Dr. Sadakatsu Ikeda is a distinguished medical oncologist specializing in precision cancer medicine. With extensive expertise in basic science, translational research, and clinical trials, he is dedicated to advancing personalized cancer treatment.

Dr. Ikeda earned his medical degree from Hokkaido University of Medicine, Japan, followed by postgraduate training at St. Luke’s International Hospital (Tokyo), Children’s Hospital Boston/Harvard Medical School, Beth Israel Medical Center, and the University of Michigan, USA. His global training shaped his expertise in oncology research and clinical practice.

Before joining Institute of Science Tokyo Hospital, Dr. Ikeda was Assistant Clinical Professor at the University of California, San Diego (UCSD), Division of Hematology, where he contributed to groundbreaking research in targeted therapies.

His work focuses on genomic-driven treatment strategies, biomarker discovery, and clinical trials to optimize cancer therapies. As one of leaders in precision oncology, he integrates cutting-edge technology to tailor treatments, improving patient outcomes.

Dr. Ikeda remains committed to translating scientific discoveries into clinical practice, mentoring future oncologists, and shaping the future of personalized cancer care.